Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
100%(4 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease

NCT03226769
completednot_applicable

Effect of TrueTear Corneal Surface Imaging

NCT03637348
completednot_applicable

Clinical Trial to Evaluate the Symptoms in Symptomatic Contact Lens Wearers Following Application of Intranasal Tear Neurostimulator Versus Control

NCT03325673
completednot_applicable

Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment

NCT03097614

Clinical Trials (4)

Showing 4 of 4 trials
NCT03226769Not Applicable

Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease

Completed
NCT03637348Not Applicable

Effect of TrueTear Corneal Surface Imaging

Completed
NCT03325673Not Applicable

Clinical Trial to Evaluate the Symptoms in Symptomatic Contact Lens Wearers Following Application of Intranasal Tear Neurostimulator Versus Control

Completed
NCT03097614Not Applicable

Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4